New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk ...

ABBOTT PARK, Ill., Aug. 29, 2022 /PRNewswire/ -- Abbott today announced new late-breaking data that show its HeartMate 3™ heart pump extends survival of advanced heart failure patients by at least ...

(RTTNews) - Abbott's (ABT) new data show that an Aspirin-free medication regimen benefits people with its HeartMate 3 heart pump. According to Abbott, the new late-breaking data show advanced heart ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant exclusively ...

Too old and too sick for a heart transplant, Arvid Herrman was given a choice: Have a mechanical pump implanted in his heart, potentially keeping him alive for several years, or do nothing and almost ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.